Provided by Tiger Fintech (Singapore) Pte. Ltd.

Merck

78.97
+1.351.74%
Post-market: 79.000.0300+0.04%19:57 EDT
Volume:9.86M
Turnover:778.72M
Market Cap:198.30B
PE:11.48
High:79.49
Open:78.30
Low:78.21
Close:77.62
Loading ...

Merck & Co. Inc. Secures FDA Approval for WELIREG® as the First Treatment for Advanced Pheochromocytoma and Paraganglioma in the U.S

Reuters
·
15 May

FDA Approves Merck’s Welireg® (Belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma (Ppgl)

THOMSON REUTERS
·
15 May

Merck & Co Inc: Welireg Label Contains a Boxed Warning That Exposure to Welireg During Pregnancy Can Cause Embryo-Fetal Harm

THOMSON REUTERS
·
15 May

US FDA expands use of Merck's cancer drug for adrenal gland tumors

Reuters
·
15 May

BRIEF-FDA Approves Belzutifan For Pheochromocytoma Or Paraganglioma

Reuters
·
15 May

FDA Approves Belzutifan for Pheochromocytoma or Paraganglioma

THOMSON REUTERS
·
15 May

FDA approves Merck’s belzutifan for pheochromocytoma or paraganglioma

TIPRANKS
·
15 May

3 Absurdly Cheap Stocks Trading Near Their 52-Week Lows

Motley Fool
·
14 May

Pharma Stock Regeneron Is a Buy, Says Citi. But Be Cautious on AbbVie, Merck. -- Barrons.com

Dow Jones
·
14 May

Ticking Keytruda Clock Moves Citi's Merck Bull to Sideline -- Market Talk

Dow Jones
·
14 May

Merck Cut to Neutral From Buy by Citigroup

Dow Jones
·
14 May

BUZZ-U.S. STOCKS ON THE MOVE-KKR, American Eagle Outfitters, Aurora Innovation

Reuters
·
14 May

BUZZ-Citi downgrades Merck on Keytruda patent cliff, growth prospects

Reuters
·
14 May

Citigroup Downgrades Merck & Co. to Neutral From Buy, Adjusts Price Target to $84 From $115

MT Newswires Live
·
14 May

Merck & Co. Inc. Stock Sheds 4.7%, Underperforms Competitors

Dow Jones
·
14 May

Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing. -- Barrons.com

Dow Jones
·
14 May

Dow's 150-Point Fall Led By Losses For UnitedHealth, Merck Stocks

Dow Jones
·
13 May

Germany's Merck Expected to Post Higher Sales, Earnings -- Earnings Preview

Dow Jones
·
13 May

Top Midday Stories: Shares Rise on US-China 90-Day Trade Ceasefire; Trump Signs Order Targeting High Drug Prices

MT Newswires Live
·
12 May

Stock Track | Merck Stock Soars 5% as Trump's Drug Pricing Order Sparks Investor Optimism

Stock Track
·
12 May